Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Interest Expenses (2018 - 2025)

Historic Interest Expenses for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to -$8.8 million.

  • AVITA Medical's Interest Expenses rose 706.71% to -$8.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.0 million, marking a year-over-year increase of 665.8%. This contributed to the annual value of -$5.0 million for FY2025, which is 665.92% up from last year.
  • AVITA Medical's Interest Expenses amounted to -$8.8 million in Q4 2025, which was up 706.71% from $1.3 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Interest Expenses ranged from a high of $1.4 million in Q3 2024 and a low of -$9.4 million during Q4 2024
  • In the last 5 years, AVITA Medical's Interest Expenses had a median value of $9000.0 in 2021 and averaged -$510388.9.
  • The largest annual percentage gain for AVITA Medical's Interest Expenses in the last 5 years was 3380000.0% (2024), contrasted with its biggest fall of 93992.87% (2024).
  • AVITA Medical's Interest Expenses (Quarter) stood at $9000.0 in 2021, then crashed by 33.33% to $6000.0 in 2022, then surged by 18600.0% to $1.1 million in 2023, then plummeted by 939.93% to -$9.4 million in 2024, then increased by 7.07% to -$8.8 million in 2025.
  • Its Interest Expenses was -$8.8 million in Q4 2025, compared to $1.3 million in Q3 2025 and $1.3 million in Q2 2025.